StemSation(TM) Signs Agreement with Award-Winning Global Marketing Agency Expects Significant Online Sales Impact by Q4
StemSation International (OTC: STSN) has partnered with First Class Alliance (FCA), a leading digital marketing agency, to enhance its online presence amidst a rapidly growing market for CBD products. This collaboration aims to boost brand awareness and improve consumer engagement. The global CBD market is projected to rise from $9.2 billion in 2020 to over $23.6 billion by 2025. Additionally, bone and joint health concerns are increasing, particularly among aging populations. StemSation focuses on developing natural wellness products that target stem cell and endocannabinoid systems.
- Partnership with FCA aims to enhance online brand awareness and sales.
- The global CBD market is projected to significantly grow, presenting opportunities for StemSation.
- Risks related to market competition and lack of public information on the company.
- Concerns over the company's ability to raise capital and continue operations as a going concern.
BOCA RATON, FL / ACCESSWIRE / August 13, 2020 / StemSation International, Inc. (OTC PINK:STSN) - a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces that it has signed an agreement with First Class Alliance (FCA), an award-winning digital marketing and licensing agency www.firstclassalliance.com that has worked with some of the most recognizable global brands in the United States.
FCA is an expert at enhancing brand awareness in the ever-changing world of digital marketing, helping companies to more effectively reach and connect with online consumers. Ray Carter, StemSation President & CEO commented, "We are very pleased to be collaborating with an impressive group like FCA to help us to stay on the forefront of digital technology and effectively share our unique and powerful story with the world".
StemSation creates and markets all-natural consumer health products that support the two most recently discovered biological systems of the human body - stem cells and endocannabinoids, releasing its first three novel products to support immune health and joint & muscle health. John Bejarano, FCA Founder & CEO commented, "FCA has a real passion for building unique brands that can make a positive impact in people's lives and StemSation certainly fits that criteria". They not only embrace change, they are innovators who create change, with impactful technology that is in timely demand given the world's current healthcare demands".
The global market for cannabidiol (CBD) is growing rapidly, estimated to reach
Bone and joint health have become a major public health concern across the globe. According to statistics, about 75 million people in the United States, Europe, and Japan have bone health concerns, and the population with bone and joint health issues is growing at alarming rates, as more baby boomers enter their 60's and early 70's globally. Joint health used to predominantly be associated with older people, but not anymore. Younger generations are concerned about their physical fitness, mobility, and joint and muscle health. https://www.mordorintelligence.com/industry-reports/global-bone-and-joint-health-supplements-market .
StemSation is a company with a long-term ‘health mission', ambitious research goals, and innovative, holistic approaches to health & wellness, and healthy longevity. Our product line shows a new pathway to wellness.
ABOUT STEMSATION INTERNATIONAL, INC.
StemSation International, Inc. (OTC "STSN") develops, manufactures and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body through using a direct selling model in which Independent Wellness Advocates ("IWAs") advertise and sell its products directly to consumers. StemSation is headquartered in Boca Raton, Florida and its website can be located at www.stemsation.global.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
FOR INFORMATION, PLEASE CONTACT:
Nicholas B. Panza, Vice President
StemSation International, Inc.
7777 Glades Road
Suite 203
Boca Raton, FL 33434
npanza@stemsationusa.com
(561) 245-7454
SOURCE: StemSation International, Inc.
View source version on accesswire.com:
https://www.accesswire.com/601560/StemSationTM-Signs-Agreement-with-Award-Winning-Global-Marketing-Agency-Expects-Significant-Online-Sales-Impact-by-Q4
FAQ
What is the partnership between StemSation International and First Class Alliance?
What is the expected impact of the partnership on StemSation's online sales?
How is the CBD market affecting StemSation International's business?
What health concerns are addressed by StemSation International's products?
